Skip to main content
OpenTrials

Clinical trial condition

Diphtheria

Explore clinical trials studying Diphtheria. Study availability and eligibility vary by location and protocol.

202 public trials 3 recruiting studies
Refine in advanced search Browse all conditions

Diphtheria trial results

Completed

Evaluation of the Immunogenicity, Safety and Reactogenicity of the Combined DTPa-IPV Vaccine in Healthy Infants

NCT00290342

Conditions
Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +7 more
Locations
  • GSK Investigational Site Bucheon-si, South Korea
  • GSK Investigational Site Daegu, South Korea
  • GSK Investigational Site Gwangju, South Korea
  • GSK Investigational Site Incheon, South Korea
View Trial Details
Completed

Immunogenicity and Safety of Kinrix + (Measles Mumps Rubella) MMR Vaccine With and Without Varicella Vaccine in Healthy Children 4-6 Years

NCT00871117

Conditions
Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +7 more
Locations
  • GSK Investigational Site Antioch, California, United States
  • GSK Investigational Site Daly City, California, United States
  • GSK Investigational Site Hayward, California, United States
  • GSK Investigational Site Redwood City, California, United States
View Trial Details
Completed

Safety and Immunogenicity of New Formulations of GlaxoSmithKline Biologicals' DTPa-HBV-IPV/Hib Vaccine (GSK217744)

NCT01248884

Conditions
Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +32 more
Locations
  • GSK Investigational Site Santo Domingo, Dominican Republic
  • GSK Investigational Site Santo Domingo, Distrito Nacional, Dominican Republic
  • GSK Investigational Site Espoo, Finland
  • GSK Investigational Site Helsinki, Finland
View all 16 locations
View Trial Details
Completed

Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine in Healthy Infants

NCT01090453

Conditions
Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +33 more
Locations
  • GSK Investigational Site Vancouver, British Columbia, Canada
  • GSK Investigational Site Winnipeg, Manitoba, Canada
  • GSK Investigational Site Hamilton, Ontario, Canada
  • GSK Investigational Site Aix-en-Provence, France
View all 34 locations
View Trial Details
Completed

US-licensed Combined Vaccine Against Tetanus & Diphtheria, Given With US-licensed Vaccine Against Meningococcal Disease

NCT00282295

Conditions
Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +12 more
Locations
  • GSK Investigational Site Chandler, Arizona, United States
  • GSK Investigational Site Little Rock, Arkansas, United States
  • GSK Investigational Site Fountain Valley, California, United States
  • GSK Investigational Site Golden, Colorado, United States
View all 24 locations
View Trial Details
Completed

Immunogenicity and Safety of GSK Biologicals' Boostrix Polio Vaccine in 3 and 4-year-old Children

NCT01245049

Conditions
Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +19 more
Locations
  • GSK Investigational Site St Austell, Cornwall, United Kingdom
  • GSK Investigational Site Southampton, Hampshire, United Kingdom
  • GSK Investigational Site Axbridge, Somerset, United Kingdom
  • GSK Investigational Site Taunton, Somerset, United Kingdom
View all 13 locations
View Trial Details

Related conditions